↓ Skip to main content

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
124 tweeters
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
170 Dimensions

Readers on

mendeley
283 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Published in
Journal for Immunotherapy of Cancer, December 2018
DOI 10.1186/s40425-018-0479-7
Pubmed ID
Authors

Saman Maleki Vareki

Twitter Demographics

The data shown below were collected from the profiles of 124 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 283 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 283 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 53 19%
Researcher 50 18%
Student > Master 44 16%
Student > Bachelor 35 12%
Other 20 7%
Other 23 8%
Unknown 58 20%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 59 21%
Medicine and Dentistry 54 19%
Immunology and Microbiology 43 15%
Agricultural and Biological Sciences 23 8%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Other 22 8%
Unknown 70 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2019.
All research outputs
#396,548
of 19,140,651 outputs
Outputs from Journal for Immunotherapy of Cancer
#74
of 2,098 outputs
Outputs of similar age
#13,471
of 404,073 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#8
of 155 outputs
Altmetric has tracked 19,140,651 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,098 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,073 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 155 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.